BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹10 Cr | ₹-4.81 Cr | ₹12 Cr | ₹7.27 Cr | ₹-2.44 Cr |
What is the latest Cash Flow from Financing Activities ratio of BAFNA PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹10 Cr |
Mar2022 | ₹-4.81 Cr |
Mar2021 | ₹12 Cr |
Mar2020 | ₹7.27 Cr |
Mar2019 | ₹-2.44 Cr |
How is Cash Flow from Financing Activities of BAFNA PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹10 Cr | Positive | |
Mar2022 | ₹-4.81 Cr | Negative | |
Mar2021 | ₹12 Cr | 68.86 | |
Mar2020 | ₹7.27 Cr | Positive | |
Mar2019 | ₹-2.44 Cr | - |
Compare Cash Flow from Financing Activities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹253.0 Cr | 21.6% | 39.2% | -0.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 21.6% |
39.2% |
-0.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses